ArticleFundamental research2025
Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification.
Article in Fundamental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- AI-based multimodal fusion for preoperative prediction of breast microcalcifications: combining mammography and tomosynthesis.BMC medical imaging · 2026Article
- Complete disappearance of ductal carcinomaAnnals of medicine and surgery (2012) · 2026Article
- Machine Learning-Based Classification of BI-RADS 4 and BI-RADS 5 Microcalcifications in Mammography Combined with DCE-MRI for Malignant-Benign Discrimination.Tomography (Ann Arbor, Mich.) · 2026Article
- AI-Driven Breast Cancer Nuclei Segmentation, Classification, and Scoring in PR-IHC Images.Diagnostics (Basel, Switzerland) · 2026Article
- The role of AI for improved management of breast cancer: Enhanced diagnosis and health disparity mitigation.Computer methods and programs in biomedicine · 2025Review
- Deep learning-based classification of benign and malignant breast microcalcifications in mammography.Scientific reports · 2025Article
- Breast cancer: pathogenesis and treatments.Signal transduction and targeted therapy · 2025Review
- Hybrid Feature Mammogram Analysis: Detecting and Localizing Microcalcifications Combining Gabor, Prewitt, GLCM Features, and Top Hat Filtering Enhanced with CNN Architecture.Diagnostics (Basel, Switzerland) · 2024Article
- Comparing Radiologists' and Artificial Intelligence Performance Detecting Suspicious Microcalcifications on Screening Mammograms: A Pilot Cross-Sectional Study.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mammography is the mainstream imaging modality used for breast cancer screening. Identification of microcalcifications associated with malignancy may result in early diagnosis of breast cancer and aid in reducing the morbidity and mortality associated with the disease. Computer-aided diagnosis (CAD) is a promising technique due to its efficiency and accuracy. Here, we demonstrated that an automated deep-learning pipeline for microcalcification detection and classification on mammography can facilitate early diagnosis of breast cancer. This technique can not only provide the classification results of mammography, but also annotate specific calcification regions. A large mammography dataset was collected, including 4,810 mammograms with 6,663 microcalcification lesions based on biopsy results, of which 3,301 were malignant and 3,362 were benign. The system was developed and tested using images from multiple centers. The overall classification accuracy values for discriminating between benign and malignant breasts were 0.8124 for the training set and 0.7237 for the test set. The sensitivity values of malignant breast cancer prediction were 0.8891 for the training set and 0.7778 for the test set. In addition, we collected information regarding pathological sub-type (pathotype) and estrogen receptor (ER) status, and we subsequently explored the effectiveness of deep learning-based pathotype and ER classification. Automated artificial intelligence (AI) systems may assist clinicians in making judgments and improve their efficiency in breast cancer screening, diagnosis, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.